Axis Capital Limited

You are currently browsing the latest version of the Axis Capital corporate website. Please click here. to access the older website.
Krishna Institute of Medical Sciences Limited
21,440 million

Primary Product

ECM

Secondary Product

IPO

Date

June 2021
Krishna Institute of Medical Sciences Limited
21,440 million

Primary Product

ECM

Secondary Product

IPO

Date

June 2021
Krishna Institute of Medical Sciences, one of the largest corporate healthcare groups in Andhra Pradesh (AP) and Telangana, raised INR 2,144 Cr in its IPO. The deal witnessed participation from marquee institutional investors in spite of multiple competing IPOs and ~95% of the anchor book was allocated to long-only investors. The IPO received good response from investors across the board.
Successfully executed the first IPO in hospital space since February 2018 and positioned KIMS as an unique healthcare company which has consistently delivered growth along with profitability and ROE: 1. Strong performance track record with fastest revenue and EBITDA growth among peers 2. Comprehensive range of services across 25+ specialities and super specialities using modern medical technology 3. Focus on patient outcomes, governance and sustainable business 4. 1.6x bed capacity compared to next largest player in AP and Telangana 5. Distinguished doctor engagement model which encourages low attrition & long term association with the group Axis Capital helped generate demand from multiple pools of capital including sovereign funds, mutual funds, AIFs and multi-strategy funds. Additionally, it marketed the deal extensively through HNI and Retail desk to ensure healthy subscription in the NII and RII categories despite multiple other ongoing IPOs.

Transactions

Supriya Lifescience
7,000 million

Primary Product: 

ECM

Secondary Product:

IPO

Date:

December 2021
Medplus
13,980 million

Primary Product: 

ECM

Secondary Product:

IPO

Date:

December 2021
Ami Organics
5,700 million

Primary Product: 

ECM

Secondary Product:

IPO

Date:

September 2021
Sanmar
38,500 million

Primary Product: 

ECM

Secondary Product:

IPO

Date:

August 2021
Clean Science
15,470 million

Primary Product: 

ECM

Secondary Product:

IPO

Date:

July 2021
India Pesticides Limited
8,000 million

Primary Product: 

ECM

Secondary Product:

IPO

Date:

June 2021
KIMDSU
21,440 million

Primary Product: 

ECM

Secondary Product:

IPO

Date:

June 2021
Rossari Biotech
3,000 million

Primary Product: 

PE

Secondary Product:

Preference Shares

Date:

April 2021
Laxmi Organic Industries
6,000 million

Primary Product: 

ECM

Secondary Product:

IPO

Date:

March 2021